[Management of acute coronary syndrome]
Maria Buske1, Hans-Josef Feistritzer1, Alexander Jobs1
1Herzzentrum Leipzig, Universitätsklinik für Kardiologie, Strümpellstr. 39, 04289, Leipzig, Deutschland.
Insights
Acute coronary syndrome (ACS) requires prompt evaluation including troponin testing for timely treatment. Secondary prevention of coronary artery disease (CAD) involves tailored medications and patient education for risk management.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Coronary artery disease (CAD) is a leading global cause of mortality.
- Acute coronary syndrome (ACS) is often the initial presentation of CAD.
- Timely diagnosis and risk-adapted treatment are critical for ACS patients.
Purpose of the Study:
- To outline the essential components of timely and comprehensive assessment for Acute Coronary Syndrome (ACS).
- To emphasize the importance of risk-adapted treatment strategies for secondary prevention in Coronary Artery Disease (CAD).
Main Methods:
- Clinical presentation evaluation
- Electrocardiogram (ECG) analysis
- High-sensitivity cardiac troponin laboratory diagnostics
- Risk stratification for treatment planning
Main Results:
- Prompt assessment integrating clinical, ECG, and troponin data facilitates immediate or early invasive coronary angiography.
- Revascularization, antithrombotic therapy, and lipid-lowering treatments are key for secondary CAD prevention.
- Individualized treatment duration and medication choice based on patient risk profile are crucial.
Conclusions:
- A systematic approach to ACS diagnosis and treatment is vital.
- Personalized secondary prevention strategies, including medication and patient education, are essential for managing CAD.
- Effective risk factor management improves long-term outcomes for CAD patients.
Abstract:
Coronary artery disease (CAD) is the leading cause of death worldwide. Acute coronary syndrome (ACS) encompasses a spectrum of diagnoses ranging from unstable angina pectoris to myocardial infarction with and without ST-segment elevation and frequently presents as the first clinical manifestation. It is crucial in this scenario to perform a timely and comprehensive assessment of patients by evaluating the clinical presentation, electrocardiogram and laboratory diagnostics using highly sensitivity cardiac troponin in order to initiate a timely and risk-adapted continuing treatment with immediate or early invasive coronary angiography. In addition to revascularization, the subsequent antithrombotic and lipid-lowering treatment plays a major role in the further secondary prevention of CAD. The choice and duration of medication over time should be tailored to the individual risk profile of the patient. Furthermore, appropriate patient education regarding risk factor management is of paramount importance.
Related Concept Videos
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Acute Pancreatitis II: Clinical Manifestations and Management
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...


